ST
Stock_Research_Today
Community Contributor
Followers117Total number of followers
Comments0Total number of comments
Member Since2025Date joined

Stock Research Today, provides investors with real-time market analysis, expert research, and curated financial content to support smarter, data-driven investment decisions.

No link added
RNXT logo
RenovoRx
ST
Stock_Research_Today
Community Contributor

Revolutionizing Cancer Treatment

A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.
View narrative
US$4.20
FV
67.1% undervalued intrinsic discount
371.30%
Revenue growth p.a.
15users have liked this narrative
3users have commented on this narrative
118users have followed this narrative
15 days ago author updated this narrative